Stevanato Group Expands Operations with New State-of-the-Art Plant in Cisterna di Latina
PIOMBINO DESE, Italy - Stevanato Group S.p.A. (NYSE: STVN), a renowned global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life science industries, has announced the opening of its cutting-edge plant in Cisterna di Latina. This new facility, spanning an impressive 65,000 square meters and employing about 200 skilled workers, is located just a few kilometers away from the Group’s first historic plant in Latina.
The Cisterna di Latina plant marks a significant milestone in Stevanato Group’s commitment to innovation and excellence in the field of drug containment and delivery. Equipped with state-of-the-art technology and adhering to the highest quality standards, the facility specializes in the production of pre-sterilized EZ-fill syringes and cartridges. These advanced solutions are pivotal in ensuring the safe and efficient administration of pharmaceuticals, catering to the evolving needs of the healthcare industry.
With the launch of this new plant, Stevanato Group aims to meet the growing demands of its global clientele, including pharmaceutical, biotechnology, and life science companies. By expanding its manufacturing capabilities, the Group reinforces its position as a leading player in the industry, further solidifying its reputation for delivering innovative and reliable solutions.
In addition to the inauguration of the Cisterna di Latina plant, Stevanato Group also revealed the successful outcome of its Annual General Meeting of Shareholders (AGM) held on May 22, 2024. All proposed resolutions were passed, further demonstrating the company’s strong governance and commitment to transparency.
The AGM marked a significant occasion for Stevanato Group as it showcases its dedication to maintaining open lines of communication with shareholders. The details of the resolutions approved by the shareholders can be found in the comprehensive explanatory report available for reference.
As Stevanato Group continues to push boundaries in the pharmaceutical, biotechnology, and life science sectors, this new plant serves as a testament to the company’s unwavering pursuit of excellence. By combining cutting-edge technology, a talented workforce, and a commitment to meeting the evolving needs of the healthcare industry, it is poised to accelerate innovation and drive positive change.
Comments